AAV8 gene therapy shows promise, but new scalable platform overcomes manufacturing challenges for consistent production.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

The MarketWatch News Department was not involved in the creation of this content.-- Kytopen continues expanding its partnership footprint in Europe through a new agreement with TQ ...

Professor Dongsheng Liu of Tsinghua University, Professor Ziyang Hao of Capital Medical University, and Researcher Yuanchen Dong of the Institute of ...

SEATTLE, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Pluristyx, Inc. today announced the formation of the Organoid COMMONS (Consortium for Organoid Manufacturing, Measurement, Optimization, and Network ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...

Spinal Cord Injury (SCI) is a devastating neurological disorder that often leads to permanent neural dysfunction. Current ...